YungShin Global Holding Corp (3705) - Total Assets

Latest as of September 2025: NT$11.97 Billion TWD ≈ $377.19 Million USD

Based on the latest financial reports, YungShin Global Holding Corp (3705) holds total assets worth NT$11.97 Billion TWD (≈ $377.19 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 3705 total equity for net asset value and shareholders' equity analysis.

YungShin Global Holding Corp - Total Assets Trend (2000–2024)

This chart illustrates how YungShin Global Holding Corp's total assets have evolved over time, based on quarterly financial data.

YungShin Global Holding Corp - Asset Composition Analysis

Current Asset Composition (December 2024)

YungShin Global Holding Corp's total assets of NT$11.97 Billion consist of 53.5% current assets and 46.6% non-current assets.

Asset Category Amount (TWD) % of Total Assets
Cash & Equivalents NT$0.00 13.3%
Accounts Receivable NT$1.77 Billion 12.8%
Inventory NT$3.15 Billion 22.8%
Property, Plant & Equipment NT$0.00 0.0%
Intangible Assets NT$8.55 Million 0.1%
Goodwill NT$0.00 0.0%

Asset Composition Trend (2000–2024)

This chart illustrates how YungShin Global Holding Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see YungShin Global Holding Corp stock valuation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: YungShin Global Holding Corp's current assets represent 53.5% of total assets in 2024, an increase from 0.0% in 2000.
  • Cash Position: Cash and equivalents constituted 13.3% of total assets in 2024, up from 9.3% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
  • Asset Diversification: The largest asset category is inventory at 22.8% of total assets.

YungShin Global Holding Corp Competitors by Total Assets

Key competitors of YungShin Global Holding Corp based on total assets are shown below.

Company Country Total Assets
Changchun High & New Technology Industries Group Inc
SHE:000661
China CN¥31.46 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Tasly Pharmaceutical Group Co Ltd
SHG:600535
China CN¥15.34 Billion
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
China CN¥15.32 Billion
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
China CN¥10.96 Billion
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
China CN¥1.54 Billion
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
China CN¥6.74 Billion
Cronos Group Inc
TO:CRON
Canada CA$1.18 Billion

YungShin Global Holding Corp - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.66 2.70 1.50
Quick Ratio 2.14 1.50 0.84
Cash Ratio 0.00 0.00 0.00
Working Capital NT$4.78 Billion NT$4.45 Billion NT$2.15 Billion

YungShin Global Holding Corp - Advanced Valuation Insights

This section examines the relationship between YungShin Global Holding Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.89
Latest Market Cap to Assets Ratio 0.03
Asset Growth Rate (YoY) 19.9%
Total Assets NT$13.80 Billion
Market Capitalization $466.59 Million USD

Valuation Analysis

Below Book Valuation: The market values YungShin Global Holding Corp's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: YungShin Global Holding Corp's assets grew by 19.9% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for YungShin Global Holding Corp (2000–2024)

The table below shows the annual total assets of YungShin Global Holding Corp from 2000 to 2024.

Year Total Assets Change
2024-12-31 NT$13.80 Billion
≈ $434.72 Million
+19.85%
2023-12-31 NT$11.51 Billion
≈ $362.70 Million
-2.87%
2022-12-31 NT$11.85 Billion
≈ $373.43 Million
-1.30%
2021-12-31 NT$12.01 Billion
≈ $378.36 Million
-4.78%
2020-12-31 NT$12.61 Billion
≈ $397.34 Million
+2.04%
2019-12-31 NT$12.36 Billion
≈ $389.39 Million
+5.05%
2018-12-31 NT$11.77 Billion
≈ $370.68 Million
+6.78%
2017-12-31 NT$11.02 Billion
≈ $347.14 Million
+8.12%
2016-12-31 NT$10.19 Billion
≈ $321.06 Million
+9.99%
2015-12-31 NT$9.26 Billion
≈ $291.90 Million
+6.60%
2014-12-31 NT$8.69 Billion
≈ $273.83 Million
+5.62%
2013-12-31 NT$8.23 Billion
≈ $259.25 Million
+11.24%
2012-12-31 NT$7.40 Billion
≈ $233.05 Million
+1.10%
2011-12-31 NT$7.32 Billion
≈ $230.52 Million
+6.00%
2010-12-31 NT$6.90 Billion
≈ $217.48 Million
+3.78%
2009-12-31 NT$6.65 Billion
≈ $209.56 Million
+3.25%
2008-12-31 NT$6.44 Billion
≈ $202.97 Million
-3.41%
2007-12-31 NT$6.67 Billion
≈ $210.14 Million
+14.51%
2006-12-31 NT$5.82 Billion
≈ $183.52 Million
+0.06%
2005-12-31 NT$5.82 Billion
≈ $183.41 Million
-16.00%
2004-12-31 NT$6.93 Billion
≈ $218.35 Million
+6.17%
2003-12-31 NT$6.53 Billion
≈ $205.65 Million
+2.64%
2002-12-31 NT$6.36 Billion
≈ $200.37 Million
+1.53%
2001-12-31 NT$6.26 Billion
≈ $197.35 Million
+12.65%
2000-12-31 NT$5.56 Billion
≈ $175.19 Million
--

About YungShin Global Holding Corp

TW:3705 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$466.59 Million
NT$14.81 Billion TWD
Market Cap Rank
#12890 Global
#465 in Taiwan
Share Price
NT$55.60
Change (1 day)
-0.18%
52-Week Range
NT$52.00 - NT$68.80
All Time High
NT$68.80
About

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, an… Read more